Shots:

• Veracyte collaborates with Acerta Pharma- a hematology research and development of AstraZeneca for providing genomic information for supporting development of oncology therapeutics
• On Dec 03- 2019 the company reported acquisition of its diagnostics rights to the NanoString nCounter platform and genomic tests for breast cancer and lymphoma
• The focus of the agreement is to expand the global footprints and the capability to treat cancer

Click here to read full press release/ article 

Ref: Veracyte | Image: Signbox